Searched for
REGULATOR EMA
Stocks in news: Sun Pharma, Tech Mahindra, Tata Motors, Voltas, ONGCIndian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despi...- Stocks in news: IFCI, Tata Motors, General Insurance Corp, Corona Remedies, HFCLMarkets extended their winning streak for the fourth consecutive session, driven by favorable global cues and sustained sector-wide buying....
- Stocks in news: Lenskart, PFC, RIL, Hindustan Zinc, Tata ConsumerIndian markets saw volatile trading on Wednesday, closing slightly down. Lenskart, PFC, RIL, Hindustan Zinc, and Tata Consumer are in focus...
- Adani Energy Solutions surges 63% in 3 months fueled by seasonality, outlook. But why brokerages are cautious?With the onset of summer, shares of Adani Energy Solutions have attracted strong investor interest, rallying over 63% in just three months....
- Paytm Payments Bank licence cancellation: Jefferies, Bernstein and Goldman decode impactPaytm shares fell 8% after RBI cancelled Paytm Payments Bank’s licence but recovered sharply as brokerages stayed bullish. Analysts see lim...
- India-New Zealand FTA to be signed on Monday, says PM Christopher LuxonIndia and New Zealand will sign a Free Trade Agreement on Monday, April 27. This landmark deal aims to boost bilateral trade significantly....
- EU regulator set to rule on Pfizer COVID pill by end-Jan, ahead of Merck - sourceThe EMA's review of Merck's pill, developed with Ridgeback Biotherapeutics, is taking longer than Pfizer's because Merck released trial dat...
- EU regulator to decide on Pfizer booster at the start of October: SourceThe EU regulator said on September 6 it had begun its evaluation of data submitted by Pfizer and BioNTech for a booster dose to be given si...
- European efforts to assess Russia’s Sputnik V vaccine stymied by data gapsSeparately, an assessment of Sputnik V by a French delegation of scientists in advance of the EMA review found that the vaccine developers ...
- Blood clots should be listed as rare Johnson & Johnson side effect, says Europe drug watchdogThe European Medicines Agency (EMA) said in a statement that it had found a "possible link" between the jab and the clots, following eight ...
- European Medicines Agency confirms clots as 'very rare' AstraZeneca side effectNo specific risk factors, including age, have been identified for thrombosis with the AstraZeneca shot, which could stem from an immune res...
- Key questions as EU watchdog rules on AstraZenecaThe EMA is the regulator for all human and animal medicines in the 27 nations of the European Union plus the European Economic Area countri...
- Russian, Chinese hackers targeted Europe drug regulatorThe Amsterdam-based European drug regulator in December reported a cyberattack in which documents relating to COVID-19 vaccines and medicin...
- Johnson & Johnson seeks vaccine approval from European UnionIn a statement on Tuesday, the Amsterdam-based medicines regulator for the European Union said it could issue an opinion by the middle of M...
- Biocon's insulin facility in Malaysia clears inspections for European marketThe facility, set up with an investment of $275 million, is designed to manufacture recombinant human insulin and insulin analogs for the g...
- Lupin submits fresh studies for two products suspended by EMALupin said that company has successfully conducted the new bio equivalence (BE) studies for the said products and submitted the report to E...
- German regulator hails European Medicine Agency's drugs suspension on GVK Bio dataThe German watchdog said it will take a decision shortly on whether to add more medicines to the list of banned drugs in the wake of the EM...
- Four European Union countries suspend authorisation of 25 drugs studied at GVK BiosciencesEuropean Medicines Agency (EMA) said in a statement that it is reviewing findings of non-compliance with good clinical practise at the GVK ...
- EU lifts drug export ban from Ranbaxy's Toansa plantThe assessment of the Toansa facility by EMA followed an inspection by the USFDA, which revealed areas of non-compliance with GMP at the si...
- Exports to Europe from Ranbaxy's two plants to remain suspendedExports from Ranbaxy plants at Toansa and Dewas to Europe will remain suspended as probes are continuing, European health regulator EMA sai...
Load More
